Impact of vitamin K dosing during sorafenib treatment for hepatocellular carcinoma: Effect on ischemic tumor cell damage caused by sorafenib.

被引:0
|
作者
Haruna, Yoshimichi
Hasegawa, Noriko
Imanaka, Kazuho
Inoue, Atsuo
Kudo, Masatoshi
机构
[1] Osaka Gen Med Ctr, Osaka, Japan
[2] Kinki Univ, Sch Med, Osaka, Japan
关键词
D O I
10.1200/JCO.2016.34.15_suppl.e15585
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e15585
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Mechanism of Action of Tumor Treating Fields (TTFields) in Combination with Sorafenib for Treatment of Hepatocellular Carcinoma
    Davidi, S.
    Shteingauz, A.
    Jacobovitch, S.
    Gotlib, K.
    Brami, C. Tempel
    Munster, M.
    Zeevi, E.
    Dor-On, E.
    Schneiderman, R. S.
    Voloshin, T.
    Haber, A.
    Giladi, M.
    Kinzel, A.
    Weinberg, U.
    Palti, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E47 - E48
  • [42] REDUCED DOSE AND DURATION OF SORAFENIB TREATMENT ARE ASSOCIATED TO TUMOR PROGRESSION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
    Ponziani, F. R.
    Annichiarico, B. E.
    Siciliano, M.
    Barone, C.
    Basso, M.
    Cesario, V.
    Campanale, M.
    Caracciolo, G.
    Garcovich, M.
    Zocco, M.
    Gigante, G.
    Rinninella, E.
    Sarno, G.
    Di Rienzo, T. A.
    D'Aversa, F.
    Gasbarrini, G.
    Gasbarrini, A.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S65 - S66
  • [43] The effect of apatinib in the treatment of sorafenib resistant metastatic hepatocellular carcinoma A case report
    Han, Zonghong
    He, Zhongming
    Wang, Caoye
    Wang, Qi
    MEDICINE, 2018, 97 (49)
  • [44] Effect of treatment with branched-chain amino acids during sorafenib therapy for unresectable hepatocellular carcinoma
    Takeda, Haruhiko
    Nishikawa, Hiroki
    Iguchi, Eriko
    Ohara, Yoshiaki
    Sakamoto, Azusa
    Saito, Sumio
    Nishijima, Norihiro
    Nasu, Akihiro
    Komekado, Hideyuki
    Kita, Ryuichi
    Kimura, Toru
    Osaki, Yukio
    HEPATOLOGY RESEARCH, 2014, 44 (03) : 302 - 312
  • [45] SYNERGISTIC ANTI-TUMOR EFFECT OF SORAFENIB IN COMBINATION WITH AKT INHIBITORS IN HEPATOCELLULAR CARCINOMA
    Feng, W. -C.
    Hsu, C. -H.
    Lin, S. -D.
    Lin, H. -H.
    Hsu, D. -W.
    Huang, C. -C.
    Chow, L. -P.
    Cheng, A. -L.
    ANNALS OF ONCOLOGY, 2012, 23 : 16 - 16
  • [46] The impact of betablocker treatment on cancer prognosis in patients with advanced hepatocellular carcinoma receiving sorafenib treatment
    Balcar, Lorenz
    Pomej, Katharina
    Mandorfer, Mattias
    Meischl, Tobias
    Mueller, Christian
    Trauner, Michael
    Reiberger, Thomas
    Pinter, Matthias
    Scheiner, Bernhard
    JOURNAL OF HEPATOLOGY, 2021, 75 : S521 - S521
  • [47] Practical Effect of Sorafenib Monotherapy on Advanced Hepatocellular Carcinoma and Portal Vein Tumor Thrombosis
    Jeong, Soung Won
    Jang, Jae Young
    Shim, Kwang Yeun
    Lee, Sae Hwan
    Kim, Sang Gyune
    Cha, Sang-Woo
    Kim, Young Seok
    Cho, Young Deok
    Kim, Hong Soo
    Kim, Boo Sung
    Kim, Kyoung Ha
    Kim, Jung Hoon
    GUT AND LIVER, 2013, 7 (06) : 696 - 703
  • [48] Small-intestinal hemorrhage caused by treatment with sorafenib for hepatocellular carcinoma and diagnosed by capsule endoscopy
    Takahashi, Y.
    Fukunishi, S.
    Nishikawa, T.
    Nouda, S.
    Sasaki, Y.
    Sanomura, M.
    Umegaki, E.
    Higuchi, K.
    ENDOSCOPY, 2013, 45 : E179 - E180
  • [49] EVALUATION OF TUMOR PERFUSION AT COMPUTED TOMOGRAPHY AS A TOOL TO DETECT THE EFFECT OF SORAFENIB TREATMENT IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC)
    Reig, M.
    Rimola, J.
    Forner, A.
    Rodriguez de Lope, C.
    Llovet, J. M.
    Ayuso, C.
    Bruix, J.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S297 - S298
  • [50] VITAMIN K1 PLUS SORAFENIB COMBINATION IS MORE EFFECTIVE THAN SORAFENIB ALONE IN ADVANCED HEPATOCELLULAR CARCINOMA - A PROSPECTIVE RANDOMIZED CONTROLLED TRIAL
    Rangegowda, D.
    Premkumar, M.
    Sharma, M. K.
    Mukund, A.
    Sarin, S. K.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S691 - S691